ATE464891T1 - Injizierbare flüssige formulierung von paracetamol - Google Patents

Injizierbare flüssige formulierung von paracetamol

Info

Publication number
ATE464891T1
ATE464891T1 AT04711333T AT04711333T ATE464891T1 AT E464891 T1 ATE464891 T1 AT E464891T1 AT 04711333 T AT04711333 T AT 04711333T AT 04711333 T AT04711333 T AT 04711333T AT E464891 T1 ATE464891 T1 AT E464891T1
Authority
AT
Austria
Prior art keywords
paracetamol
liquid formulation
injectable liquid
solution
antipyretic
Prior art date
Application number
AT04711333T
Other languages
English (en)
Inventor
Tho Nguyen-Xuan
Original Assignee
Tho Nguyen-Xuan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32749656&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE464891(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tho Nguyen-Xuan filed Critical Tho Nguyen-Xuan
Application granted granted Critical
Publication of ATE464891T1 publication Critical patent/ATE464891T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
AT04711333T 2003-02-14 2004-02-16 Injizierbare flüssige formulierung von paracetamol ATE464891T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0301972A FR2851164B1 (fr) 2003-02-14 2003-02-14 Formulation liquide injectable de paracetamol
PCT/CH2004/000085 WO2004071502A1 (fr) 2003-02-14 2004-02-16 Formulation liquide injectable de paracetamol

Publications (1)

Publication Number Publication Date
ATE464891T1 true ATE464891T1 (de) 2010-05-15

Family

ID=32749656

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04711333T ATE464891T1 (de) 2003-02-14 2004-02-16 Injizierbare flüssige formulierung von paracetamol

Country Status (13)

Country Link
US (1) US8071619B2 (de)
EP (1) EP1592414B1 (de)
JP (1) JP4861162B2 (de)
CN (1) CN100546574C (de)
AT (1) ATE464891T1 (de)
AU (1) AU2004212269B2 (de)
CA (1) CA2517491C (de)
DE (1) DE602004026684D1 (de)
EA (1) EA008908B1 (de)
ES (1) ES2344697T3 (de)
FR (1) FR2851164B1 (de)
MA (1) MA27748A1 (de)
WO (1) WO2004071502A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005037653A1 (de) 2005-08-05 2007-02-15 Theraselect Gmbh Stabile, flüssige Formulierung von Paracetamol
RU2419421C2 (ru) * 2006-07-18 2011-05-27 Хенфарма Лабораторио С.Л. Инъецируемая жидкая композиция парацетамола
EP1992334A1 (de) * 2007-05-08 2008-11-19 Docpharma NV/SA Lagerfähige Formulierung eines oxidationsempfindlichen phenolhaltigen Arzneimittels, insbesondere Paracetamol, mit einer wässrigen, durch ein temperaturgeregeltes Herstellungsverfahren desoxidierten Arzneimittellösung
AR067047A1 (es) * 2007-06-18 2009-09-30 Combino Pharm Sl Formulaciones acuosas de acetaminofen para inyeccion.
AR067048A1 (es) * 2007-06-18 2009-09-30 Combino Pharm Sl Formulaciones acuosas de acetaminofen para inyeccion.
JP5909750B2 (ja) * 2007-11-13 2016-04-27 マリンクロット アイピー 低用量静脈内アセトアミノフェン
WO2009098716A2 (en) * 2008-01-17 2009-08-13 Aptuit Laurus Private Limited Stable pharmaceutical aqueous compositions
FR2926992B1 (fr) * 2008-02-06 2011-01-14 Moly Pharma Formulation d'une solution de paracetamol injectable,procede de preparation et de conditionnement d'une telle solution et dispositif de conditionnement d'une telle solution
ES2321906B1 (es) * 2008-11-28 2010-02-09 Laboratorios Normon, S.A. Composicion farmaceutica que comprende una solucion acuosa de paracetamol.
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US20110207824A1 (en) * 2010-02-25 2011-08-25 Moly Pharma Formulation of an injectable paracetamol solution, method for preparing and packaging such a solution and device for packaging such a solution
PT2377516E (pt) 2010-04-14 2012-07-02 Braun Melsungen Ag Composição acetaminofeno
DK2389923T3 (da) * 2010-05-19 2013-03-18 Uni Pharma Kleon Tsetis Pharmaceutical Lab S A Stabil klar til brug injicerbar paracetamol-formulering
ES2414557B1 (es) 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
ITMI20121154A1 (it) * 2012-06-29 2013-12-30 Sint Sa Soluzione iniettabile di acetaminofene per la somministrazione spinale
US20140303254A1 (en) * 2013-04-08 2014-10-09 InnoPharma Licensing LLC Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation
BR102014005885B1 (pt) 2014-03-13 2021-04-13 Biotec Biológica Indústria Farmacêutica Ltda E.P.P Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso
CN108289869B (zh) * 2014-04-28 2021-08-27 奥佛麦德公司 使用通过酚羟基连接的药学活性的对乙酰氨基酚二聚体治疗疼痛的方法
CN110642677B (zh) * 2019-08-30 2023-05-26 浙江工业大学 双芳基衍生物的制备、双芳基衍生物及应用
CN112782332A (zh) * 2021-02-04 2021-05-11 深圳市药品检验研究院（深圳市医疗器械检测中心） 一种对乙酰氨基酚药品中对氨基酚杂质的hplc检测方法
CN114965754B (zh) * 2022-05-13 2024-04-09 陕西必康制药集团控股有限公司 对乙酰氨基酚片中有关物质及抑菌剂的检测方法
CN115385818B (zh) * 2022-09-01 2023-09-29 江苏海洋大学 一种扑热息痛杂质及制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS545022A (en) * 1977-06-14 1979-01-16 Zenyaku Kogyo Kk Production of solution agent containing aqueous licorice extract and acetoaminophenone
EP0173729B1 (de) * 1984-03-14 1990-10-17 Jérôme CORBIERE Verfahren zum lösen von wirksubstanzen und auf diese weise erhaltene arzneimittel
CN1104495A (zh) * 1993-08-11 1995-07-05 广州明兴制药厂 复方双氯灭痛注射液(康迪注射液)及其制备工艺
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
EP1285667B1 (de) * 1997-11-18 2006-06-14 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Pharmazeutische injizierbare Lösungen, die Paracetamol und Kombinationen aus Paracetamol mit anderen Aktivsubstanzen enthalten
IT1301976B1 (it) * 1998-07-31 2000-07-20 Angelini Ricerche Spa Composizione farmaceutica iniettabile a base di paracetamolo
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
DE10112325A1 (de) * 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
ITMI20012135A1 (it) * 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo

Also Published As

Publication number Publication date
CN100546574C (zh) 2009-10-07
AU2004212269B2 (en) 2009-05-28
EA008908B1 (ru) 2007-08-31
FR2851164A1 (fr) 2004-08-20
EP1592414B1 (de) 2010-04-21
JP4861162B2 (ja) 2012-01-25
CN1750818A (zh) 2006-03-22
WO2004071502A1 (fr) 2004-08-26
DE602004026684D1 (de) 2010-06-02
FR2851164B1 (fr) 2005-04-22
US20060084703A1 (en) 2006-04-20
CA2517491C (fr) 2012-07-31
MA27748A1 (fr) 2006-02-01
AU2004212269A1 (en) 2004-08-26
EP1592414A1 (de) 2005-11-09
EA200501302A1 (ru) 2006-04-28
ES2344697T3 (es) 2010-09-03
US8071619B2 (en) 2011-12-06
CA2517491E (fr) 2004-08-26
CA2517491A1 (fr) 2004-08-26
JP2006517544A (ja) 2006-07-27

Similar Documents

Publication Publication Date Title
ATE464891T1 (de) Injizierbare flüssige formulierung von paracetamol
DE69833942D1 (de) Verwendung einer neurotoxintherapie zur behandlung von prostata erkrankungen
EA201070121A1 (ru) Лекарственная форма, содержащая слитый белок glp-1-fc
NO20026196D0 (no) Kinazolinditosylatsalt forbindelser
ATE254928T1 (de) Stabilisierte zusammensetzung mit nootropen wirkstoffen
ATE429243T1 (de) G-csf-flüssigformulierung
EP1581656A4 (de) MODULATION DER EXPRESSION VON HIF1a UND HIF2a
ATE430589T1 (de) Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen
DE60224449D1 (de) Gebrauchsfertige paracetamol injektionslösungen enthaltend propylenglykol als einziges cosolvens
EA200401345A1 (ru) Лечение гастропареза
CY1107707T1 (el) Αναστολεις της φωσφοδιεστερασης-5 για την προφυλαξη και/ή τη θεραπεια της πυλαιας υπερτασης
EA200100168A1 (ru) Схема лечения при введении фенилацетилглутамина, фенилацетилизоглутамина и/или фенилацетата
DE60116642D1 (de) Verbindungen mit cytochrom p450ra1 hemmenden aktivität
RU2009103818A (ru) Водная лекарственная композиция 4-[(4-карбоксибутил)-{2-[(4-фенетилбензил)окси)-фенетил}амино)метил)-бензойной кислоты
Griffin et al. Molecular mechanisms of surface-dependent activation of Hageman factor (Factor XII)
DE60336417D1 (de) Flüssige zusammensetzungen mit 3,7-diazabicycloä3,3,1ü nonanen zur behandlung von anti-arrhythmischen ereignissen
DE60318423D1 (de) Behandlung des typ 1 diabetes vor und nach expression von prädispositionsmarkern
EP1441740A4 (de) Antisense-modulation der matrix-metalloproteinase-1-expression
NO20045437L (no) Medikamenter for behandling av akutte dysfunksjoner i portavenesirkulasjon og hepatisk sirkulasjon
WO2006010127A3 (en) Therapeutic compound and treatments
DE60306344D1 (de) Behandlung von typ i diabetes mellitus mit wachstumshormonantagonisten
RU2004103180A (ru) Способ лечения хронических диффузных заболеваний печени применением курса внутривенных инфузий растворов гипохлорита натрия
BR0309375A (pt) Tratamento de sìndrome metabólica
Madej et al. Proteolytic enzymes in the treatment of acute pancreatitis
RU2001132208A (ru) Способ термохимической обработки призабойной зоны пласта

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties